Absolute quantification of myocardial blood flow with 13N- ammonia and 3-dimensional PET

Journal of Nuclear Medicine

Volumn 48, Issue 11, 2007, Pages 1783-1789

  Schepis, Tiziano ^a   Gaemperli, Oliver ^a   Treyer, Valerie ^a   Valenta, Ines ^a   Burger, Cyrill ^a   Koepfli, Pascal ^a   Namdar, Mehdi ^a   Adachi, Itaru ^b   Alkadhi, Hatem ^a   Kaufmann, Philipp A ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

3 dimensional PET; 13N NH3; Image reconstruction algorithms; Myocardial blood flow

Indexed keywords

ADENOSINE; AMMONIA N 13; CONTRAST MEDIUM; LUTETIUM; LUTETIUM YTTRIUM OXYORTHOSILICATE; OXYORTHOSILICATE; UNCLASSIFIED DRUG; YTTRIUM;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; FILTERED BACKPROJECTION; FOURIER REBINNING; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART VENTRICLE SEPTUM; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LOW DRUG DOSE; MALE; ORDERED SUBSETS EXPECTATION MAXIMIZATION; PARAMETER; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPROJECTION ALGORITHM; STATISTICAL ANALYSIS; STEADY STATE; TECHNIQUE;

AGED; AMMONIA; CORONARY CIRCULATION; HEART; HUMANS; MALE; MIDDLE AGED; NITROGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 36049050150     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.044099     Document Type: Article

References (30)

1. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981;63:1259-1272.
2. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation. 1992;86:1004-1017.
3. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
4. 3 and gated PET. J Nucl Med. 2002;43:999-1005.
5. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
6. Cherry SR, Dahlbom M, Hoffman EJ. 3D PET using a conventional multislice tomograph without septa. J Comput Assist Tomogr. 1991;15:655-668.
7. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med. 1997;38:1614-1623.
8. Badawi RD, Marsden PK, Cronin BF, Sutcliffe JL, Maisey MN. Optimization of noise-equivalent count rates in 3D PET. Phys Med Biol. 1996;41:1755-1776.
9. Cherry SR, Woods RP, Hoffman EJ, Mazziotta JC. Improved detection of focal cerebral blood flow changes using three-dimensional positron emission tomography. J Cereb Blood Flow Metab. 1993;13:630-638.
10. 15O-water and three-dimensional positron emission tomography. J Cereb Blood Flow Metab. 1997;17:732-739.
11. 15O brain activation studies: dose fractionation strategies for rCBF and signal enhancing protocols. IEEE Trans Med Imaging. 1998;17:979-985.
12. 18F-FDG PET oncology studies performed on an LSO-based scanner. J Nucl Med. 2006;47:23-31.
13. 82Rb PET studies. J Nucl Med. 2001;42:701-706.
14. 15O and 3-dimensional PET: an experimental validation. J Nucl Med. 2002;43:1031-1040.
15. 82Rb myocardial perfusion PET imaging. J Nucl Med. 2003;44:1350-1356.
16. Roelants V, Bol A, Bernard X, et al. Direct comparison between 2-dimensional and 3-dimensional PET acquisition modes for myocardial blood flow absolute quantification with O-15 water and N-13 ammonia. J Nucl Cardiol. 2006;13:220-224.
17. Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ. NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med. 2006;47:1960-1967.
18. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:384-389.
19. Koepfli P, Hany TF, Wyss CA, et al. CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner. J Nucl Med. 2004;45:537-542.
20. Defrise M, Kinahan PE, Townsend DW, Michel C, Sibomana M, Newport DF. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging. 1997;16:145-158.
21. Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med. 2003;44:146-154.
22. Koepfli P, Wyss CA, Namdar M, et al. Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. J Nucl Med. 2004;45:1626-1631.
23. Namdar M, Koepfli P, Grathwohl R, et al. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol. 2006;47:405-410.
24. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
25. 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol. 1996;3:494-507.
26. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med. 1992;33:1243-1250.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
28. 18F-FDG study. Eur J Nucl Med Mol Imaging. 2003;30:1510-1519.
29. Katoh C, Ruotsalainen U, Laine H, et al. Iterative reconstruction based on median root prior in quantification of myocardial blood flow and oxygen metabolism. J Nucl Med. 1999;40:862-867.
30. 18F-FDG PET. J Nucl Med. 2004;45:2008-2015.